Efficacy and Safety of TAK-007, Cord Blood-Derived CD19 CAR-NK Cells, in Adult Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (NHL)
Publication
, Conference
Darrah, JM; Varadarajan, I; Mehta, A; Saultz, JN; McKinney, M; Ghosh, M; Gergis, U; Bende, G; Kasar, S; Hupf, B; Chen, S; Sellner, L; Karmali, R
Published in: Blood
November 5, 2024
Duke Scholars
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 5, 2024
Volume
144
Issue
Supplement 1
Start / End Page
95 / 95
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Darrah, J. M., Varadarajan, I., Mehta, A., Saultz, J. N., McKinney, M., Ghosh, M., … Karmali, R. (2024). Efficacy and Safety of TAK-007, Cord Blood-Derived CD19 CAR-NK Cells, in Adult Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (NHL). In Blood (Vol. 144, pp. 95–95). American Society of Hematology. https://doi.org/10.1182/blood-2024-194807
Darrah, Justin M., Indumathy Varadarajan, Amitkumar Mehta, Jennifer N. Saultz, Matthew McKinney, Monalisa Ghosh, Usama Gergis, et al. “Efficacy and Safety of TAK-007, Cord Blood-Derived CD19 CAR-NK Cells, in Adult Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (NHL).” In Blood, 144:95–95. American Society of Hematology, 2024. https://doi.org/10.1182/blood-2024-194807.
Darrah JM, Varadarajan I, Mehta A, Saultz JN, McKinney M, Ghosh M, et al. Efficacy and Safety of TAK-007, Cord Blood-Derived CD19 CAR-NK Cells, in Adult Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (NHL). In: Blood. American Society of Hematology; 2024. p. 95–95.
Darrah, Justin M., et al. “Efficacy and Safety of TAK-007, Cord Blood-Derived CD19 CAR-NK Cells, in Adult Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (NHL).” Blood, vol. 144, no. Supplement 1, American Society of Hematology, 2024, pp. 95–95. Crossref, doi:10.1182/blood-2024-194807.
Darrah JM, Varadarajan I, Mehta A, Saultz JN, McKinney M, Ghosh M, Gergis U, Bende G, Kasar S, Hupf B, Chen S, Sellner L, Karmali R. Efficacy and Safety of TAK-007, Cord Blood-Derived CD19 CAR-NK Cells, in Adult Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (NHL). Blood. American Society of Hematology; 2024. p. 95–95.
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 5, 2024
Volume
144
Issue
Supplement 1
Start / End Page
95 / 95
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology